LEO Re-acquires Dermatology Drug Rights from Warner Chilcott
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 10 (Table of Contents)
Published: 5 Oct-2009
DOI: 10.3833/pdr.v2009.i10.1254 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
LEO Pharma repurchased the US product rights to psoriasis treatments, Talconex®, Talconex Scalp® and Dovonex®, and the dermatology pipeline from Warner Chilcott for nearly US$1 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS